A method has been developed for the simultaneous detection and quantitation of five different (2-hydroxyethyl)-DNA adducts (HE-DNA adducts) that could be formed as a result of exposure to ethylene oxide (EO). In addition to the major N7-HE-guanine (N7-HEG) adducts this assay can also measure the less prevalent but potentially more 
INTRODUCTION

Ethylene oxide (EO) is a widely used chemical intermediate and gaseous sterilant
1 , which is also formed endogenously through the metabolism of ethylene 2, 3 by cytochrome P450-dependant monooxygenases in vivo 4, 5 . Possible endogenous sources of ethylene include lipid peroxidation 6 and intestinal bacteria metabolism 7 , together quaternary ammonium ion, leading to cleavage of the N-glycosydic bond 19 , which if not repaired can result in an apurinic (AP) site. N7-HEG adducts are not considered to be promutagenic themselves, although presence of AP sites during DNA replication could result in miscoding 20, 21 . Being the predominant EO alkylation product however, measures of N7-HEG can provide a valuable biomarker of exposure. Very little is known about the properties of the other 2-hydroxyethyl DNA adducts, which together account for less than 5% of the reaction products when EO is incubated with DNA in vitro 2 . It seems likely that if formed, they may contribute to the biological effects of EO, given that O 6 -alkylguanine adducts have been widely demonstrated to be mutagenic 22 . In addition, N3-HE-2'-deoxycytidine undergoes spontaneous hydrolytic deamination to form N3-HEdU 23, 24 , which has been suggested as a potentially mutagenic adduct 25 and adduction at the N1-position of adenine is proposed to be a miscoding lesion 26, 27 .
A variety of methods for the detection and quantitation of EO-derived DNA adducts have been reported, however, virtually all published assays have focused solely on measurement of the major N7-HEG adduct, excluding the lesser formed adducts 28, 29 .
32
P-Postlabelling [30] [31] [32] [33] [34] approaches can detect N7-HEG in control rat liver at levels of 1 adduct per 10 7 nucleotides 33 and similar amounts have been detected in the lymphocytes of unexposed humans 34 . However, the assay procedure can be rather lengthy, it provides no structural information and the analysis is highly inefficient due to spontaneous depurination of the N7-HEG adduct, which must remain in the nucleotide form in order to be detectable. In a comparison of different immunoassay methods for N7-HEG detection 35 an immunoslot blot assay was found to be the most sensitive, although the limit of detection (LOD) was in the region of 0.3 adducts per 6 , considerably higher than other methods. Furthermore, immunoassays require antibodies specific to the adduct in question and these are not currently available for any other HE-adducts, limiting detection to the major N7-HEG lesion. HPLC with fluorescence detection has been used to measure the dosimetry of N7-HEG in rodents and could also detect O 6 -HEGuanine and N3-HEAdenine adducts in rats exposed to high doses (300 ppm) of EO, but the technique lacked the necessary sensitivity to detect O 6 -HEG and N3-HEA in unexposed animals 36 . Mass spectrometry based methods afford greater specificity and the sensitivity of these systems is continually improving [37] [38] [39] . As very little is known about the frequency and biological effects of the lesser formed HE adducts, we have developed and validated a novel, highly sensitive, and specific LC-MS/MS method for the simultaneous detection and quantitation of five adducts that can potentially be derived from ethylene oxide exposure. This is useful to the study of HE-DNA adducts as previous assays could only detect the N7-HEG adduct. We also demonstrate various applications of the assay; for the detection of levels of endogenous/ background HE adducts as well as adducts induced by EO treatment in samples including DNA extracted from the liver of control and treated rats.
EXPERIMENTAL
Caution:
EO is classified as a human carcinogen and should be handled with the appropriate precaution.
Chemicals
Ethylene oxide gas (99.8 % purity), nucleosides and DNA bases for the synthesis of adduct standards and the enzymes snake venom phosphodiesterase and DNase I were purchased from Sigma (Poole, Dorset, UK starting material and all other significant peaks were collected and evaporated to dryness for structural analysis, to identify those fractions containing 2-HE adducts. In some cases it was necessary to perform a second HPLC purification on the collected fractions and this was carried out using identical conditions.
Structural Characterisation of HE-DNA adducts
The UV spectrum was obtained for each potential adduct containing fraction (nucleoside and base) using a Hitachi U-3010 spectrophotometer (Hitachi, Wokingham, Berkshire) and compared to available published data for ethylene oxide DNA adducts 18 . Samples with UV spectra consistent with the addition of a hydroxyethyl group were subject to MS analysis.
HPLC fractions were analysed by mass spectrometry using a Micromass Quattro BioQ, equipped with a pneumatically assisted electrospray source (Waters, Hertfordshire, UK). The mass spectrometer was tuned using a thymidine standard in MeOH (5 pmoles/µL). Each HPLC peak residue was redissolved in methanol and analysed by continuous infusion. Analysis was carried out in the positive ion mode, and the molecular mass of the components of each peak was determined using a total ion scan ( Figure 2 ). The structure of each potential HE-DNA adduct standard was further confirmed by MS/MS, and compared to the spectra for the fully characterized adducts published by Li et al. 18 UV spectrophotometry was then used to determine the concentration of each of the standards, using published wavelengths and extinction coefficients 18 .
The reaction of EO with dA produced two different 2-hydroxyethyl adducts and MS/MS analysis of both fractions produced identical spectra, each containing the predicted [M+H] + ion at m/z 296. However, the fractions varied significantly in their chromatographic properties; the first eluted at 13.5 min and the second, at 18.2 min on the HPLC separation system, indicating different sites of hydroxyethylation. In order to identify the individual adducts isolated, a small aliquot of each HPLC fraction was removed and NaOH (1 M) was added to increase the pH of the solution to 12. After incubation at 37ºC for 18 h the samples were neutralised with HCl (1 M) and the resulting products analysed by HPLC. The retention time of peak A remained at 13.5 min, however peak B appeared to have structurally rearranged into peak A, suggesting that peak B was N1-HEdA and peak A was N 6 -HEdA 40 .
Isolation and LC-MS/MS analysis of HE-DNA adducts.
Typically , 41 , then the values were converted to adducts/ 10 8 nucleotides. Figure 3 gives an overview of the assay procedure for the isolation and quantitation of HE-adducts.
N7-HEG
Validation Parameters
Linearity of calibration was determined by measuring the ratio of peak areas of the four different HE-adduct standards to the was defined as a signal to noise baseline ratio of 7:1.
Measurement of HE-DNA adducts in DNA.
A variety of samples were analysed for the presence of HE-DNA adducts to demonstrate potential applications of the LC-MS/MS assay. Background levels of adducts were measured in commercially available control calf thymus (CT) DNA, and liver DNA from an untreated (control) male F-344 rat, provided from another study as described by Marsden, et al. 42 In addition, adducts were measured in a pSP189
plasmid DNA isolated from E.coli bacteria 43 that had been exposed to EO in vitro, by reacting with 10mM EO for 24h at 37ºC in water. HE-DNA adducts were isolated from the three types of DNA, purified by HPLC and quantitated by LC-MS/MS as detailed above.
RESULTS AND DISCUSSION
We have developed a sensitive and specific method allowing the simultaneous The structures of these two adducts were further confirmed by LC-MS/MS analysis, since the spectra produced by the dissociation of N7-HEG (m/z = 196) is comparable to that reported by Liao et al. 45 ( Figure 2C ).
Even though the assay utilised SRM as the analysis method, which allows the selective monitoring of a number of specific transitions, in any DNA sample HEadducts would be present at extremely low levels relative to the normal, unmodified nucleosides. Therefore, enrichment procedures were necessary to minimise interference with adduct quantitation and obtain the maximum sensitivity. The labile nature of the N7-HEG adduct was exploited in the selective isolation of this adduct from the intact DNA by thermal depurination and filtration. In addition to the desired adduct, the filtrate from this procedure would be expected to contain other depurinating lesions present endogenously or produced by EO exposure, such as N3-HEA. Although other published assays analyse N7-HEG levels directly after hydrolysis and filtration 43, 45, 48 , this approach resulted in inconsistent measures of the The remaining HE-adducts were isolated by enzymatic digestion of the DNA recovered from the microcon filter, which is then separated by HPLC using a system capable of resolving the HE-adducts of interest from unmodified nucleosides ( Figure   4 ), with the exception of N3-HEdU, which co-elutes with dT and is isolated by a further HPLC purification step. The addition of a nucleoside adduct internal standard LC-MS/MS analysis of nucleoside HE-adduct standards subjected to thermal hydrolysis prior to going through the assay procedure, confirmed the depurination step did not cause loss of these adducts due to degradation. This was evidenced by the fact adduct levels for control and hydrolysed samples varied by no more than ± 5%.
The collected fractions from the preparative HPLC runs are then combined and analysed for the presence of the 5 different HE-adducts simultaneously by LC-MS/MS, by measuring a specific transition for each adduct. For nucleoside adducts, the optimum transition was found to be dissociation of the adducted nucleoside (or equivalent sodiated species for N3-HEdU) into adducted base through loss of the sugar moiety, whilst for base adducts, dissociation to the base as a consequence of loss of the 2-hydroxyethyl group was most suitable. The best possible separation conditions and solvent system were established using the synthetic standards, and a Supelcosil C 18 , 250 x 2.1mm, 5µ column, eluted with an isocratic mobile phase of 40% MeOH in 0.5% acetic acid, was found capable of providing the maximum overall sensitivity with optimum peak shape and retention time ( Figure 5A ). N3-HEA, N3-HEdT and N3-HEdC were not incorporated into this assay but could however be introduced if required.
Assay Validation
In order to validate this assay, the following criteria were determined: linearity, precision, repeatability, inter-day variability, intra-day variability and the LOQ. HEdU. Measurement of N3-HEdU will always be an approximate value as an internal standard is ideally required to compensate for losses due to the additional HPLC step.
Quantitation of HE-DNA adduct levels in DNA.
Very little is known about the formation or biological consequences of HE-DNA adducts apart from the major N7-HEG lesion. Although, based on evidence from in vitro binding studies, the other potential HE-adducts account for a small proportion of total adduct formation by EO, and it is possible that under some circumstances they may be present at significant levels in vivo. The development of this assay provides, for the first time, a method that could potentially detect these adducts in DNA samples from exposed animals, humans or cultured cells, to determine whether they are formed and at what levels, using just a single DNA sample. The assay can also be applied to mechanistic studies, for example in combination with the supF forward mutation assay, which would allow mutagenic potency to be related to HE-DNA adduct profiles.
In order to demonstrate the possible applications of this assay, we have analysed levels of endogenous/background and EO-induced HE-adducts in various types of DNA as shown in Table 1 and Figure 6 . The additional peaks present in the channels for N1-HEdA and O 6 -HEdG are artefactual. MS/MS analysis suggests that they are related to the adducts and it is possible that they could be corresponding residual nucleoside N3-HEA and N7-HEG adducts. N7-HEG was detected in liver DNA from control rats at levels of ~8 adducts/10 8 nucleotides, which is comparable with that found by Wu et al., who reported endogenous adduct levels in the range of 5-8 adducts/10 8 nucleotides 46 and similar to the 1-3.5 adducts/10 8 nucleotides described in the Marsden study 43 . The DNA from the livers of rats treated with 1.5 mg/kg was also analysed (data not shown) but N7-HEG was still the only HE-adduct detected,
suggesting that this dose is not high enough to induce the formation of N1-HEdA and O 6 -HEdG, or that they are formed but at a limit that is below the LOD of this assay. In untreated CT DNA, N7-HEG was the only HE-adduct detected, at background levels of ~10 adduct/10 8 nucleotides. For there to be endogenous/background adducts present in commercially available DNA is not unexpected, for example C8-(1-hydroxyethyl)-guanine adducts have previously been reported in CT DNA 47 . O 6 -HEdG has previously been detected and measured in different rat tissues by fluorescence-HPLC at approximate levels of 3 adducts/10 7 nucleotides but only after 2 weeks of exposure to 300 ppm EO 11 . In this study, O 6 -HEdG was not detected in any of the control DNA samples but exposure of pSP189 plasmid to a high concentration of EO (10mM) over a 24h period, induced measurable levels of O 6 -HEG (~575/10 8 nucleotides), as shown in Figure 6 , whilst also increasing the total N7-HEG and N1-HEdA to ~415166 and 24216 adducts/10 8 nucleotides, respectively.
N1-HEdA has only previously been observed in DNA treated with 14 C-EO in vitro 17 , and only quantitated after a large-scale 50 mM reaction of EO with CT DNA 18 .
More recently, the method of choice for the detection of N7-HEG adducts has been LC-MS. Leclerq et al., described an assay using LC-MS with single ion monitoring which achieved an LOD of 1 pmole injected onto the column, and measured 3 N7-HEG adducts/10 8 nucleotides in DNA from blood exposed to EO in vitro 48 . A similar method was published by Liao et al., with an LOD of 128 fmoles and the authors also demonstrated that using LC-MS/MS with SRM detection improved the sensitivity, decreasing the LOD further to 16 fmoles 45 . In comparison, the highest LOD of the five HE-adducts analysed in this study is 25 fmoles injected onto the column. The most sensitive published method to date for the detection of N7-HEG appears to be the Gas Chromatography-Electron Capture-Mass Spectrometry method described by Wu et al., which had an LOD of 600 amoles 46 . The assay described here is slightly more sensitive, for both N7-HEG and N1-HEdA, with an LOD of 500 amoles, and has the advantage that it does not require the production of a pentafluorobenzyl-N7-HEG derivative as part of the sample preparation step.
In developing an LC-MS/MS method for the simultaneous measurement of a number of different DNA adducts there is inevitably a compromise in sensitivity in order to achieve detection of all five HE-adducts. However, the LOD for the N7-HEG adduct is still more sensitive than any previous published method and with advances in technology, for example nanospray or ultra high pressure HPLC (UPLC), the sensitivity may be further improved in the future. In addition, if one wished to study any single HE-adduct specifically then the current assay could be tailored in favour of that particular adduct by slight alteration of the MS conditions to maximise the sensitivity for the adduct of interest. Multi-adduct analysis is becoming a more common approach for the study of the effects of chemical carcinogens; recently, Brink et al., have described a method for the determination of three promutagenic adducts formed as a result of exposure to dimethylnitrosamine, 49 and an assay for the quantification of four structurally different adducts caused by oxidative stress has been reported by Churchwell et al. 50 Since most chemical carcinogens form a variety of lesions, it is more informative to quantitatively determine the adduct profile rather than focus on a single adduct and these methods make this approach possible in a rapid and sensitive manner.
Conclusion
In summary, a sensitive and selective LC-MS/MS assay has been developed and validated for the simultaneous detection and quantitation of five different HE-DNA adducts that can be formed as a result of EO exposure. This allows a more comprehensive study of HE-adduct formation which has not previously been possible.
To demonstrate its utility, this assay has so far been employed in the measurement of 
